Univar Inc. (UNVR) Downgraded by Zacks Investment Research to Hold
According to Zacks, “Univar Inc. is a distributor of chemicals and innovative services. The Company offers solvents, resins, pigments, acids, bases, surfactants, glycols, inorganic compounds and alcohols. It also offers transportation and warehousing infrastructure, chemicals and hazardous materials handling services. The Company’s operating geographical segments include Univar USA, Univar Canada, Univar Europe and the Middle East as well as Rest of World. It serves coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries. Univar Inc. is headquartered in Downers Grove, Illinois. “
Other research analysts have also issued research reports about the stock. Jefferies Group initiated coverage on shares of Univar in a research report on Friday, September 9th. They issued a buy rating and a $26.00 price target for the company. Bank of America Corp. set a $22.00 price target on shares of Univar and gave the stock a buy rating in a research report on Thursday, August 11th. Barclays PLC increased their price target on shares of Univar from $20.00 to $21.00 and gave the stock an equal weight rating in a research report on Tuesday, August 16th. Finally, Wells Fargo & Co. reissued a hold rating on shares of Univar in a research report on Sunday, September 4th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of Buy and an average target price of $22.50.
Shares of Univar (NYSE:UNVR) traded up 0.28% during mid-day trading on Tuesday, hitting $21.55. The stock had a trading volume of 25,523 shares. The firm’s 50 day moving average price is $20.90 and its 200-day moving average price is $19.15. Univar has a one year low of $10.65 and a one year high of $22.76. The company has a market cap of $2.97 billion, a PE ratio of 47.05 and a beta of 1.24.
Univar (NYSE:UNVR) last announced its quarterly earnings data on Tuesday, August 9th. The company reported $0.29 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.13. The business earned $2.30 billion during the quarter, compared to analyst estimates of $2.23 billion. Univar had a net margin of 0.75% and a return on equity of 7.73%. The firm’s revenue for the quarter was down 9.9% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.12) earnings per share. On average, equities research analysts anticipate that Univar will post $0.72 earnings per share for the current fiscal year.
In other news, Director Christopher D. Pappas bought 5,000 shares of the business’s stock in a transaction on Friday, August 12th. The shares were bought at an average cost of $19.33 per share, for a total transaction of $96,650.00. Following the completion of the acquisition, the director now owns 55,088 shares in the company, valued at approximately $1,064,851.04. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Christopher Oversby sold 22,241 shares of the stock in a transaction on Tuesday, September 20th. The stock was sold at an average price of $20.01, for a total transaction of $445,042.41. Following the completion of the sale, the insider now owns 108,666 shares in the company, valued at $2,174,406.66. The disclosure for this sale can be found here. 2.49% of the stock is currently owned by company insiders.
A number of large investors have recently bought and sold shares of UNVR. Longview Asset Management LLC purchased a new stake in Univar during the second quarter valued at $227,835,000. Jennison Associates LLC raised its stake in Univar by 182.6% in the second quarter. Jennison Associates LLC now owns 3,471,352 shares of the company’s stock valued at $65,643,000 after buying an additional 2,242,816 shares during the period. Southpoint Capital Advisors LP raised its stake in Univar by 4.2% in the first quarter. Southpoint Capital Advisors LP now owns 3,325,000 shares of the company’s stock valued at $57,124,000 after buying an additional 135,275 shares during the period. Vanguard Group Inc. raised its stake in Univar by 6.1% in the second quarter. Vanguard Group Inc. now owns 2,874,867 shares of the company’s stock valued at $54,364,000 after buying an additional 164,151 shares during the period. Finally, First Eagle Investment Management LLC purchased a new stake in Univar during the second quarter valued at $27,242,000. Institutional investors own 80.18% of the company’s stock.
Univar Inc is a distributor of commodity and specialty chemicals. The Company’s segments include Univar USA (USA); Univar Canada (Canada); Univar Europe, the Middle East and Africa (EMEA), and Rest of World. The Rest of World segment includes developing businesses in Latin America, including Brazil and Mexico, and the Asia-Pacific region.
Receive News & Stock Ratings for Univar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar Inc. and related stocks with our FREE daily email newsletter.